Inventor · disambiguated record
Anima Ghosal
Also filed as: GHOSAL ANIMA
4 granted patents·7 pending applications·35 citations·filing 2001–2011
71Inventor score
Top patents by PatentIndex Score
11 records- 0184US6982251B2Substituted 2-azetidinones useful as hypocholesterolemic agentsSCHERING CORP·Filed 2002·Granted Jan 3, 2006·29 cites·27 claims
- 0269US7825121B2Piperazine derivatives useful as CCR5 antagonistsSCHERING CORP·Filed 2005·Granted Nov 2, 2010·2 cites·8 claims
- 0364US7312223B2Metabolite of xanthine Phosphodiesterase 5 inhibitor and derivatives thereof useful for treatment of erectile dysfunctionSCHERING CORP·Filed 2004·Granted Dec 25, 2007·3 cites·15 claims
- 0457US7271174B2Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseasesSCHERING CORP·Filed 2004·Granted Sep 18, 2007·1 cites·7 claims
- 0552US2007207949A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 0651US2007232527A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 0750US2007287664A1Combinations of HCV protease inhibitor(s) and CYP3A4 inhibitor(s), and methods of treatment related theretoSCHERING CORP·Filed 2007·Application pending·0 cites
- 0840US2010291034A1Combinations of hcv protease inhibitor(s) and cyp3a4 inhibitor(s), and methods of treatment related theretoSCHERING CORP·Filed 2010·Application pending·0 cites
- 0940US2006276404A1Medicaments and methods combining a HCV protease inhibitor and an AKR competitorGHOSAL ANIMA·Filed 2006·Application pending·0 cites
- 1036US2002137690A1Sugar-substituted 2-azetidinones useful as hypocholesterolemic agentsSCHERING CORP·Filed 2001·Application pending·0 cites
- 1130US2014162942A1Inhibition of cyp3a drug metabolismGHOSAL ANIMA·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Anima Ghosal files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →